One of our funded PhD students, Ogechi Nkeonye has been presented with an award for her work in pancreatic cancer research. Ogechi was presented with the award by the National Cancer Research Institute (NCRI) for her work at the University of Wolverhampton's Faculty of Science and Engineering. She also scooped a £250 bursary from the NCRI national conference held recently in Liverpool.
Ogechi is part of a team funded by a Pancreatic Cancer UK Research Innovation Fund grant which was awarded more than £73,000 and will investigate the effectiveness of using a treatment for alcoholism, Disulfiram, to treat pancreatic cancer.
Ogechi delivered a speech and presented her work on this promising avenue of research at the 2017 NCRI Conference in Liverpool. She said: “I’m blessed to be able to work as part of a very supportive team of committed and dedicated individuals. I work in the laboratory all week and am already seeing some very positive results. I’m honoured to have received this recognition from the National Cancer Research Institute and it was wonderful to profile the work of the team on a national platform.”
Professor Weiguang Wang, Professor of Experimental Cancer Therapeutics at the University of Wolverhampton and principal investigator for the project highlighted the promising nature of the work Ogechi and the team have been doing.
“We’re very pleased our research was chosen for funding by Pancreatic Cancer UK and that we have been able to continue our work with Disulfiram and test its effectiveness in treating pancreatic cancer.
“Current treatment options for pancreatic cancer are limited, and most patients diagnosed with the disease have a poor prognosis. This is an extremely promising area of investigation and if we’re successful, could lead to new options to improve outcomes for people with pancreatic cancer.”